Literature DB >> 35111593

Longitudinal clustering analysis and prediction of Parkinson's disease progression using radiomics and hybrid machine learning.

Mohammad R Salmanpour1,2, Mojtaba Shamsaei1, Ghasem Hajianfar3, Hamid Soltanian-Zadeh4,5, Arman Rahmim2,6.   

Abstract

BACKGROUND: We employed machine learning approaches to (I) determine distinct progression trajectories in Parkinson's disease (PD) (unsupervised clustering task), and (II) predict progression trajectories (supervised prediction task), from early (years 0 and 1) data, making use of clinical and imaging features.
METHODS: We studied PD-subjects derived from longitudinal datasets (years 0, 1, 2 & 4; Parkinson's Progressive Marker Initiative). We extracted and analyzed 981 features, including motor, non-motor, and radiomics features extracted for each region-of-interest (ROIs: left/right caudate and putamen) using our standardized standardized environment for radiomics analysis (SERA) radiomics software. Segmentation of ROIs on dopamine transposer - single photon emission computed tomography (DAT SPECT) images were performed via magnetic resonance images (MRI). After performing cross-sectional clustering on 885 subjects (original dataset) to identify disease subtypes, we identified optimal longitudinal trajectories using hybrid machine learning systems (HMLS), including principal component analysis (PCA) + K-Means algorithms (KMA) followed by Bayesian information criterion (BIC), Calinski-Harabatz criterion (CHC), and elbow criterion (EC). Subsequently, prediction of the identified trajectories from early year data was performed using multiple HMLSs including 16 Dimension Reduction Algorithms (DRA) and 10 classification algorithms.
RESULTS: We identified 3 distinct progression trajectories. Hotelling's t squared test (HTST) showed that the identified trajectories were distinct. The trajectories included those with (I, II) disease escalation (2 trajectories, 27% and 38% of patients) and (III) stable disease (1 trajectory, 35% of patients). For trajectory prediction from early year data, HMLSs including the stochastic neighbor embedding algorithm (SNEA, as a DRA) as well as locally linear embedding algorithm (LLEA, as a DRA), linked with the new probabilistic neural network classifier (NPNNC, as a classifier), resulted in accuracies of 78.4% and 79.2% respectively, while other HMLSs such as SNEA + Lib_SVM (library for support vector machines) and t_SNE (t-distributed stochastic neighbor embedding) + NPNNC resulted in 76.5% and 76.1% respectively.
CONCLUSIONS: This study moves beyond cross-sectional PD subtyping to clustering of longitudinal disease trajectories. We conclude that combining medical information with SPECT-based radiomics features, and optimal utilization of HMLSs, can identify distinct disease trajectories in PD patients, and enable effective prediction of disease trajectories from early year data. 2022 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Parkinson’s disease (PD); hybrid machine learning methods; longitudinal clustering; outcome prediction

Year:  2022        PMID: 35111593      PMCID: PMC8739095          DOI: 10.21037/qims-21-425

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  63 in total

1.  A global geometric framework for nonlinear dimensionality reduction.

Authors:  J B Tenenbaum; V de Silva; J C Langford
Journal:  Science       Date:  2000-12-22       Impact factor: 47.728

Review 2.  The heterogeneity of idiopathic Parkinson's disease.

Authors:  Thomas Foltynie; Carol Brayne; Roger A Barker
Journal:  J Neurol       Date:  2002-02       Impact factor: 4.849

3.  Robust identification of Parkinson's disease subtypes using radiomics and hybrid machine learning.

Authors:  Mohammad R Salmanpour; Mojtaba Shamsaei; Abdollah Saberi; Ghasem Hajianfar; Hamid Soltanian-Zadeh; Arman Rahmim
Journal:  Comput Biol Med       Date:  2020-11-25       Impact factor: 4.589

4.  Clinical heterogeneity in newly diagnosed Parkinson's disease.

Authors:  Bart Post; Johannes D Speelman; Rob J de Haan
Journal:  J Neurol       Date:  2008-03-17       Impact factor: 4.849

Review 5.  The second brain and Parkinson's disease.

Authors:  Thibaud Lebouvier; Tanguy Chaumette; Sébastien Paillusson; Charles Duyckaerts; Stanislas Bruley des Varannes; Michel Neunlist; Pascal Derkinderen
Journal:  Eur J Neurosci       Date:  2009-08-27       Impact factor: 3.386

6.  Disease progression in Parkinson subtypes: the PPMI dataset.

Authors:  Darko Aleksovski; Dragana Miljkovic; Daniele Bravi; Angelo Antonini
Journal:  Neurol Sci       Date:  2018-08-14       Impact factor: 3.307

7.  Effects of asymmetric dopamine depletion on sensitivity to rewarding and aversive stimuli in Parkinson's disease.

Authors:  Sari Maril; Sharon Hassin-Baer; Oren S Cohen; Rachel Tomer
Journal:  Neuropsychologia       Date:  2013-02-17       Impact factor: 3.139

8.  Mood, side of motor symptom onset and pain complaints in Parkinson's disease.

Authors:  Patrick McNamara; Karina Stavitsky; Erica Harris; Orsolya Szent-Imrey; Raymon Durso
Journal:  Int J Geriatr Psychiatry       Date:  2010-05       Impact factor: 3.485

9.  Parkinson subtypes progress differently in clinical course and imaging pattern.

Authors:  Carsten Eggers; David J Pedrosa; Deniz Kahraman; Franziska Maier; Catharine J Lewis; Gereon R Fink; Matthias Schmidt; Lars Timmermann
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

Review 10.  Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease.

Authors:  Daniela Berg; Ronald B Postuma; Bastiaan Bloem; Piu Chan; Bruno Dubois; Thomas Gasser; Christopher G Goetz; Glenda M Halliday; John Hardy; Anthony E Lang; Irene Litvan; Kenneth Marek; José Obeso; Wolfgang Oertel; C Warren Olanow; Werner Poewe; Matthew Stern; Günther Deuschl
Journal:  Mov Disord       Date:  2014-03-11       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.